Table 3.
SF‐36 domain | No facial paresis | Facial paresis | BF | t | P | d |
---|---|---|---|---|---|---|
M (SD) | M (SD) | |||||
SF‐36 total score | 75.21 (18.66) | 66.92 (18.73) | 14.55 | 1.52 | .068 | 0.44 |
Physical functioning | 81.30 (27.60) | 78.96 (27.94) | 1.59 | 0.30 | .387 | 0.08 |
Social functioning | 71.20 (30.02) | 60.94 (26.40) | 8.39 | 1.25 | .110 | 0.36 |
Physical role functioning | 70.11 (36.29) | 42.71 (42.97) | 107.41 | 2.36 | .012 | 0.69 |
Emotional role functioning | 85.79 (25.08) | 72.53 (36.60) | 13.15 | 1.47 | .075 | 0.42 |
Mental health | 76.96 (17.88) | 73.75 (17.95) | 2.71 | 0.61 | .272 | 0.18 |
Vitality and energy | 55.71 (18.81) | 51.65 (15.95) | 3.71 | 0.80 | .215 | 0.23 |
Bodily pain | 85.76 (22.76) | 78.96 (22.90) | 5.51 | 1.02 | .157 | 0.30 |
General health perceptions | 75.83 (21.74) | 76.83 (16.36) | 0.75 | 0.18 | .571 | 0.05 |
Note: BF for the hypothesis that VS patients with facial paresis experience lower health‐related quality of life than VS patients without facial paresis. P represents significance based on a directional (one‐tailed) t‐test.
Abbreviation: BF, Bayesian factor.